Longboard Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030
Updated on 04/27/2024
Longboard Pharmaceuticals Stock Forecast and Price Target
Longboard Pharmaceuticals's stock is projected to advance by 102.84% from the previous closing price if it reaches the average target of $40.00 by the year's end, as reputable analysts recently projected. This potential upside is calculated on a high-end estimate of $60.00 and a low-end estimate of $30.00.
102.84% Upside
Longboard Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, Price for Longboard Pharmaceuticals has grown by 100.00%, going from $0.00 to $0.00. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach $0.00 – an increase of 100.00%. Over the next six years, experts anticipate that Fair Value growth for Longboard Pharmaceuticals will be 100.00%.
.jpg)
Longboard Pharmaceuticals EBITDA Forecast for 2023 - 2025 - 2030
In the last year, Longboard Pharmaceuticals's EBITDA has grown, increasing from $-27.84M to $-44.79M – an increase of 60.88%. The next year, 0 experts forecast that Longboard Pharmaceuticals's EBITDA will decrease by 37.84%, reaching $-27.84M. In 2030, professionals predict that Longboard Pharmaceuticals's EBITDA will decrease by 16.26%, reaching $-37.51M.
Longboard Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030
Longboard Pharmaceuticals's EBIT has increased by 540.00% In the last two years, going from $-7.00M to $-44.80M. According to the 0 analysts polled, in the next year, Longboard Pharmaceuticals's EBIT will fall by 50.19%, reaching $-22.31M. By 2030, professionals believe that Longboard Pharmaceuticals's EBIT will have decreased by 34.74%, falling to $-29.24M.
Longboard Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, EPS for Longboard Pharmaceuticals has grown by 100.00%, going from $-1.93 to $0.00. In the coming year, analysts are expecting an increase in EPS, predicting it will reach $0.00 – an increase of 100.00%. Over the next six years, experts anticipate that EPS growth for Longboard Pharmaceuticals will be 100.00%.
Site Navigation
.jpg)